Paclitaxel
- Product NDC
- 70534-001
- 11-digit product format
- 705340001
- Labeler code
- 70534
- Product ID
- 70534-001_0c51fd28-42c2-4584-9c40-91945cd26810
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Paclitaxel
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- INTRAVENOUS
- Labeler
- HBT Labs, Inc.
- Application
- NDA211875
- Marketing category
- NDA
- Marketing start
- 2022-09-27
- Marketing end
- 0000-00-00
- Substance
- PACLITAXEL
- Active strength
- 100 mg/20mL
- Pharmacologic classes
- Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70534-001-00 | 70534000100 | 1 VIAL in 1 CARTON (70534-001-00) > 20 mL in 1 VIAL | 1 vial | 2022-09-27 | 0000-00-00 | No | No | Current |